Jazz Pharmaceuticals
Manufacturing · Ireland · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Waterloo Exchange Fifth floor Waterloo R...Phone Number
+35316347800Website
www.jazzpharma.comRevenue
$4.6 BillionStock Symbol
JAZZIndustry
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc is a global biopharmaceutical company headquartered in Dublin, Ireland, founded in 2003. The company develops and commercializes medicines for serious diseases with limited treatment options, focusing on neuroscience, including sleep medicine and movement disorders, and oncology, including hematologic malignancies and solid tumors. Jazz maintains a global presence with offices and manufacturing facilities across the U.S., UK, Ireland, and Italy and advances its portfolio through internal R&D, acquisitions, and licensing partnerships.Explore more
Jazz Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Jazz Pharmaceuticals
Compare insights from companies similar to Jazz Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$1.7B
1K - 5K
Private
$18M
1992
Sean GormanDirector, Business Planning & Operations Medical Office Chief & Chief Marketing Officer
Jazz Pharmaceuticals Tech Stack
A closer look at the technologies used by Jazz Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Jazz Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Jazz Pharmaceuticals plc is a global biopharmaceutical company headquartered in Dublin, Ireland, founded in 2003. The company develops and commercializes medicines for serious diseases with limited treatment options, focusing on neuroscience, including sleep medicine and movement disorders, and oncology, including hematologic malignancies and solid... Read More
